The Dangerous Practice of Using Promethazine for Infant Sleep in Pakistan

In Pakistan, the use of Promethazine (Phenergan) to induce sleep in infants, including those under one year old, is a troubling practice that poses significant health risks. While some caregivers turn to this medication for convenience, its use for sedation in young children is not medically approved and can be dangerous.

The Therapeutic Goods Administration (TGA), Australia's regulatory authority for medicines, has advised against using Promethazine Hydrochloride (Phenergan) in children under six due to risks of psychiatric and central nervous system side effects. This recommendation follows a review by Sanofi-Aventis Healthcare, highlighting potential dangers for young children.

Why Promethazine is Unsafe for Infants:

1. Respiratory Depression: The drug can suppress breathing, which is life-threatening for infants.
2. Neurological Risks: Side effects like hyperactivity, irritability, or severe drowsiness can hinder brain development.
3. Overdose Hazards: Even slight dosing errors may lead to seizures or unconsciousness.
4. No Medical Endorsement: Global health authorities, including the World Health Organization (WHO), do not recommend sedatives for infants without strict medical supervision.

Safe Sleep Practices for Babies:

• Create a Sleep Routine: Establish calming rituals such as gentle rocking or lullabies.
• Address Discomfort: Ensure the baby is fed, clean, and in a comfortable sleep environment.
• Consult a Pediatrician: For ongoing sleep issues, seek professional advice instead of using medication.

Promoting awareness among caregivers about these risks is essential to protect children from potential harm and encourage healthier sleep habits.